Hyperparathyroidism Secondary

• CLINICAL_TRIALS trial_result · 2022-05-19
  Clinical Trial Update: Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After Parathyroidectomy [Phase 3]

  A Phase 3 trial reports that Sodium Zirconium Cyclosilicate lowers hyperkalemia after parathyroidectomy.

• CLINICAL_TRIALS trial_result · 2021-09-30
  Clinical Trial Update: Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease [Phase 4]

  Phase 4 trial updating cholecalciferol supplementation in restless leg syndrome patients with chronic kidney disease has been withdrawn.

• CLINICAL_TRIALS trial_result · 2017-03-27
  Clinical Trial Update: Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis [Phase 3]

  Phase 3 clinical trial update evaluating the efficacy and safety of etelcalcetide in treating secondary hyperparathyroidism in CKD patients …

• CLINICAL_TRIALS trial_result · 2017-03-27
  Clinical Trial Update: Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis [Phase 3]

  A Phase 3 extension study of etelcalcetide in secondary hyperparathyroidism due to chronic kidney disease on hemodialysis has completed with…

• CLINICAL_TRIALS trial_result · 2016-12-19
  Clinical Trial Update: Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease [Phase 1]

  Phase 1 trial evaluating cinacalcet in children with chronic kidney disease completed with results posted in 2016.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2014-04-25
  Clinical Trial Update: Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis [Phase 4]

  A Phase 4 trial comparing cinacalcet with traditional vitamin D for secondary hyperparathyroidism in hemodialysis patients has completed and…